ASU pharma spinout wins $1.5M NIH grant

Sonoran Biosciences, an early stage pharmaceutical company spun out of Arizona State University, has received a $1.48 million research grant for its antibiotic gel to treat prosthetic joint infections.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

*